Brookline Capital Initiates Coverage On Palisade Bio With Buy Rating, Announces Price Target of $38
Brookline Capital Initiates Coverage On Palisade Bio With Buy Rating, Announces Price Target of $38
Brookline Capital發起對Palisade Bio的買入評級，宣佈目標股價爲38美元
Brookline Capital analyst Kumaraguru Raja initiates coverage on Palisade Bio (NASDAQ:PALI) with a Buy rating and announces Price Target of $38.
Brookline Capital分析師Kumaraguru Raja開始覆蓋Palisade Bio（納斯達克：PALI），給予買入評級，並公佈目標股價爲38美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間